Evidence map›Paper›PMID 34284323›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2021

COVID-19 Lockdown Effects on Acute Stroke Care in Latin America.

Virginia A Pujol-Lereis, Alan Flores, Miguel A Barboza, Carlos Abanto-Argomedo, Pablo Amaya, Hernán Bayona, Pablo Bonardo, Luis Diaz-Escobar, Maia Gomez-Schneider, Fernando Góngora-Rivera and 12 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Social Distancing, Stroke Admissions and Stroke Mortality During the COVID-19 Pandemic: A Multicenter, Longitudinal Study.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Virginia A Pujol-LereisDepartamento de Neurología Vascular, Centro Integral de Neurología Vascular, Fleni, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: vpujol@fleni.org.ar.
Alan FloresStroke Unit. Neurology Department, Hospital Universitari Joan XXIII, Tarragon, Spain.
Miguel A BarbozaNeurosciences Department, Hospital Dr. Rafael Calderón Guardia (CCSS), San José, Costa Rica.
Carlos Abanto-ArgomedoDepartamento de Enfermedades Neurovasculares, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Pablo AmayaStroke Program, Neurology Deparment, Fundación Valle del Lili, Cali, Colombia.
Hernán BayonaCentro de ACV, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Pablo BonardoServicio de Neurología, Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Luis Diaz-EscobarUnidad de Ictus, Hospital de Clínicas, FCM UNA, San Lorenzo, Paraguay.
Maia Gomez-SchneiderSanatorio de Los Arcos, Ciudad Autónoma de Buenos Aires, Instituto de Neurología y Neurocirugía, Argentina.
Fernando Góngora-RiveraServicio de Neurología, Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México; Centro de Investigación y Desarrollo en Ciencias de la Salud (CIDICS), Universidad Autónoma de Nuevo León, Monterrey, México.
Pablo M LavadosUnidad de Neurología Vascular, Servicio de Neurología, Departamento de Neurología y Psiquiatría, Clínica Alemana de Santiago, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Carolina LeonDepartamento de Neurología, Hospital Regional del ISSSTE "Dr. Valentín Gómez Farías", Zapopan, México.
Adriana LuraschiUnidad de Stroke, Servicio de Neurología, Hospital "Dr. Ignacio Pirovano", Ciudad Autónoma de Buenos Aires, Argentina.
Juan Manuel Marquez-RomeroDepartamento de Neurología, Hospital General de Zona 2, Instituto Mexicano del Seguro Social, Aguascalientes, México.
Sheila C Ouriques-MartinsDepartamento de Neurología, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Víctor Hugo NaviaHospital Padre Hurtado, SSMSO, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Angélica Ruiz-FrancoServicio de Neurología, Hospital Juárez, Ciudad de México, México.
Miguel Ángel VencesDepartamento de Neurología, Hospital Nacional Edgardo Rebagliati Martins, Essalud, Lima, Perú.
María Cristina ZurrúServicio de Neurología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Antonio ArauzClínica de Enfermedad Vascular Cerebral, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, Ciudad de México, México.
Sebastián F AmerisoDepartamento de Neurología Vascular, Centro Integral de Neurología Vascular, Fleni, Ciudad Autónoma de Buenos Aires, Argentina.
Latin American Stroke rEgistry (LASE) COVID-19 Collaborators.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCOVID-19 pandemic has forced important changes in health care worldwide. Stroke care networks have been affected, especially during peak periods. We assessed the impact of the pandemic and lockdowns in stroke admissions and care in Latin America. MATERIALS AND

methodsA multinational study (7 countries, 18 centers) of patients admitted during the pandemic outbreak (March-June 2020). Comparisons were made with the same period in 2019. Numbers of cases, stroke etiology and severity, acute care and hospitalization outcomes were assessed.

resultsMost countries reported mild decreases in stroke admissions compared to the same period of 2019 (1187 vs. 1166, p = 0.03). Among stroke subtypes, there was a reduction in ischemic strokes (IS) admissions (78.3% vs. 73.9%, p = 0.01) compared with 2019, especially in IS with NIHSS 0-5 (50.1% vs. 44.9%, p = 0.03). A substantial increase in the proportion of stroke admissions beyond 48 h from symptoms onset was observed (13.8% vs. 20.5%, p < 0.001). Nevertheless, no differences in total reperfusion treatment rates were observed, with similar door-to-needle, door-to-CT, and door-to-groin times in both periods. Other stroke outcomes, as all-type mortality during hospitalization (4.9% vs. 9.7%, p < 0.001), length of stay (IQR 1-5 days vs. 0-9 days, p < 0.001), and likelihood to be discharged home (91.6% vs. 83.0%, p < 0.001), were compromised during COVID-19 lockdown period.

conclusionsIn this Latin America survey, there was a mild decrease in admissions of IS during the COVID-19 lockdown period, with a significant delay in time to consultations and worse hospitalization outcomes.

Indexed as

Cause of DeathCOVID-19Endovascular ProceduresFemaleHealth Care SurveysHospitalizationHospital MortalityHumansLatin AmericaLength of StayMalePatient AdmissionPatient DischargePractice Patterns, Physicians'StrokeTime FactorsAcute stroke therapyCOVID-19Developing countriesLatin AmericaLockdownStroke

Identifiers

PMID34284323
PMCPMC9186152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.